Clinical, Economic Impact of Nonfatal Firearm Injuries Explored

MONDAY, April 4, 2022 (HealthDay News) -- Nonfatal firearm injuries lead to increases in diagnoses of pain disorders, psychiatric disorders, and substance use disorders, with coincident increases in health care spending and use among survivors, according to a study published online April 5 in the Annals of Internal Medicine.
Zirui Song, M.D., Ph.D., from Harvard Medical School in Boston, and colleagues conducted a cohort study to measure changes in clinical and economic outcomes after nonfatal firearm injuries among survivors and their family members. A total of 6,498 survivors of firearm injuries were matched to 32,490 controls, and 12,489 family members of survivors were matched to 62,445 controls.
The researchers found that in the first year after injury, medical spending increased $2,495 per person per month and cost sharing increased $102 per person per month (402 and 176 percent, respectively) among survivors after nonfatal firearm injury versus controls; this increase was driven by an increase of $25,554 in spending and $1,112 in cost sharing per survivor (4,122 and 1,917 percent, respectively) in the first month. Relative to the control group, all categories of spending increased. Survivors had increases in pain diagnoses, psychiatric disorders, and substance use disorders after firearm injury (40, 51, and 85 percent, respectively) relative to controls, accompanied by increases in pain and psychiatric medications. Compared with controls, family members had a 12 percent increase in psychiatric disorders.
"Nonfatal firearm injuries have meaningful economic and clinical implications for survivors and their family members," the authors write.
Related Posts
Vibration Therapy May Help Body, Mind in People With MS
THURSDAY, Nov. 11, 2021 (HealthDay News) -- Multiple sclerosis patients might be...
¿Qué tan preocupado debe estar el mundo sobre la gripe aviar en humanos?
MARTES, 14 de febrero de 2023 (HealthDay News) -- Una cepa de influenza aviar...
FDA Approves First Pill to Treat Moderate-to-Severe Crohn’s Disease
FRIDAY, May 19, 2023 (HealthDay News) -- Patients with Crohn’s disease have a...
Early Antiplatelet Therapy With Mechanical Thrombectomy Shows Benefits
TUESDAY, Aug. 15, 2023 (HealthDay News) -- Early use of antiplatelet treatment...
